Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

J Am Acad Dermatol. 2024 Feb;90(2):261-268. doi: 10.1016/j.jaad.2023.07.1047. Epub 2023 Sep 30.

Abstract

Background: Merkel cell carcinoma (MCC) is often treated with surgery and postoperative radiation therapy (PORT). The optimal time to initiate PORT (Time-to-PORT [ttPORT]) is unknown.

Purpose: We assessed if delays in ttPORT were associated with inferior outcomes.

Methods: Competing risk regression was used to evaluate associations between ttPORT and locoregional recurrence (LRR) for patients with stage I/II MCC in a prospective registry and adjust for covariates. Distant metastasis and death were competing risks.

Results: The cohort included 124 patients with median ttPORT of 41 days (range: 8-125 days). Median follow-up was 55 months. 17 (14%) patients experienced a LRR, 14 (82%) of which arose outside the radiation field. LRR at 5 years was increased for ttPORT >8 weeks vs ≤ 8 weeks, 28.0% vs 9.2%, P = .006. There was an increase in the cumulative incidence of MCC-specific death with increasing ttPORT (HR = 1.14 per 1-week increase, P = .016).

Limitations: The relatively low number of LRRs limited the extent of our multivariable analyses.

Conclusions: Delay of PORT was associated with increased LRR, usually beyond the radiation field. This is consistent with the tendency of MCC to spread quickly via lymphatics. Initiation of PORT within 8 weeks was associated with improved locoregional control and MCC-specific survival.

Keywords: Merkel Cell; adjuvant; carcinoma; dermatologic surgical procedures; patient outcome assessment; radiotherapy; sentinel lymph node biopsy; skin neoplasms; wound healing.

MeSH terms

  • Carcinoma, Merkel Cell* / pathology
  • Carcinoma, Merkel Cell* / radiotherapy
  • Carcinoma, Merkel Cell* / surgery
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Sentinel Lymph Node Biopsy
  • Skin Neoplasms* / radiotherapy
  • Skin Neoplasms* / surgery